Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 53.01% is 93% above its 5-year average of 27.44%, near the high end of its 5-year range (3.13%–53.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.93% above its 12-month average of 41.77%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 53.01%.
DEBT TO ASSETS RATIO
53.01%
DEBT TO ASSETS RATIO AVG TTM
41.77%
DEBT TO ASSETS RATIO AVG 3Y
34.24%
DEBT TO ASSETS RATIO AVG 5Y
27.44%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+26.93%
CURRENT VS 3Y AVG
+54.85%
CURRENT VS 5Y AVG
+93.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+58804.08%
vs the sector median at left
TScan Therapeutics, Inc.
Market Cap
$16.82M
Debt to Assets Ratio
53.01%
TTM Avg
41.77%
3Y Avg
34.24%
5Y Avg
27.44%
Market Cap
$16.84M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.74M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.64M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.52M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.82M | 53.01% | 41.77% | 34.24% | 27.44% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 0.00% | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | 0.03% | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $16.72M | 0.42% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | 0.14% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | 0.77% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.31M | 0.00% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.39M | 0.26% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.06% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | 0.69% | N/A | N/A | N/A |
Debt/Assets
53.0%
Debt/Equity
1.32
Current Ratio
3.37
Interest Coverage
-49.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 53.01% |
| 2026-03-31 | 45.81% |
| 2025-12-31 | 41.15% |
| 2025-09-30 | 36.47% |
| 2025-06-30 | 32.39% |
| 2025-03-31 | 29.17% |
| 2024-12-31 | 26.24% |
| 2024-09-30 | 25.96% |
| 2024-06-30 | 25.26% |
| 2024-03-31 | 38.10% |
| 2023-12-31 | 33.96% |
| 2023-09-30 | 29.85% |
| 2023-06-30 | 27.68% |
| 2023-03-31 | 49.15% |
| 2022-12-31 | 43.19% |
| 2022-09-30 | 20.49% |
| 2022-06-30 | 3.44% |
| 2022-03-31 | 3.36% |
| 2021-12-31 | 3.21% |
| 2021-09-30 | 3.13% |
| 2021-06-30 | 5.22% |
| 2021-03-31 | 5.07% |
| 2020-12-31 | 14.95% |
| 2019-12-31 | 9.90% |
